Mohammed Rehman, DO
Neurology · Detroit, MINPI 1316157225
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (44.7%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by AstraZeneca at 25.8% of the total. Reporting peaked in 2021 at $8,514 and has fallen 96.3% since, to $317 in 2025.
Across 91 payments — averaging $231.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$5K
- Penumbra, Inc.$4K
- Medical Device Business Services, Inc.$3K
- Abbott$2K
- Portola Pharmaceuticals, LLC$2K
- Stryker$2K
- plus $3K from 10 others
What the payments were for
- Speaking & faculty fees$7,05033%
- Travel & lodging$9,40345%
- Food & beverage$4,59522%
- Gifts$40%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 6 | $5,425 |
| Penumbra, Inc. | 16 | $4,007 |
| Medical Device Business Services, Inc. | 13 | $2,552 |
| Abbott | 17 | $2,309 |
| Portola Pharmaceuticals, LLC | 2 | $1,811 |
| Stryker | 10 | $1,707 |
| Microvention, Inc. | 5 | $1,428 |
| Medtronic(2 entities) | 8 | $675 |
| Johnson & Johnson | 6 | $485 |
| Haemonetics Corporation | 2 | $227 |
| Rapid Medical Ltd | 1 | $159 |
| Route 92 Medical, Inc. | 1 | $149 |
| Terumo Medical Corporation | 1 | $44 |
| EKOS Corporation | 1 | $37 |
| Boston Scientific | 1 | $20 |
| Edwards Lifesciences | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ANDEXXA$7,175
- Penumbra System$3,868
- Pulsar Vascular PulseRider Aneurysm Neck Reconstruction Device$2,273
- TRUFILL$2,273
- OMNILINK ELITE$1,508
- TARGET$1,366
- STENT$1,024
- WEB Aneurysm Embolization System$659
- Embotrap$222
- PERCLOSE PROGLIDE$220
- TIGERTRIEVER 17 REVASCULARIZATION DEVICE$159
- COMANECI 17$159
- Pipeline$151
- SURPASS EVOLVE$139
- SOLITAIRE X$131
- TEG6s HEMOSTASIS SYSTEM$128
- Xact carotid stent system$112
How this compares
$21,052 in reported general payments places this provider in the 85th percentile of 652 neurology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 17 | $126 |
Paid to pharmacies, not to this prescriber.
Other neurology in Detroit
- Bisena BulicaDetroit$900K
- Evanthia BernitsasDetroit$255K
- Andrew RussmanDetroit$118K
- Alex CheblDetroit$68K
- Tobias WalbertDetroit$56K
- Panayiotis VarelasDetroit$48K
- Aaron EllenbogenFarmington Hills$1.6M
- Matthew HoltzmanWayne$1.4M
- Richard TroschFarmington Hills$1.2M
- Wade CooperAnn Arbor$991K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.